YouTube Facebook LinkedIn Google+ Twitter Xinginstagram rss  

BMS Set to Win on Cancer Combinations

May 16, 2013 | Bristol-Myers Squibb's approved drug, Yervoy, is being tested in combination with several experimental drugs to treat advanced melanoma. The combination sets Bristol-Myers up for wins no matter which combination comes out on top. Forbes 
Click here to login and leave a comment.  


Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact Terry Manning, 781.972.1349.